Acceder Registro /

JUAN CABEZAS HERRERA

Buscador

Martínez-López de Castro A, Nieto-Cerón S, Aurelio PC, Galbis-Martínez L, Latour-Pérez J, Torres-Lanzas J, Tovar-Zapata I, Martínez-Hernández P, Rodríguez-López JN, Cabezas-Herrera J. Cancer-associated differences in acetylcholinesterase activity in bronchial aspirates from patients with lung cancer. Clin Sci (Lond). 2008 Oct;115(8):245-53. doi: 10.1042/CS20070393. PubMed PMID: 18211261.
AÑO: 2008; IF: 4.187
Sánchez-del-Campo L, Otón F, Tárraga A, Cabezas-Herrera J, Chazarra S, Rodríguez-López JN. Synthesis and biological activity of a 3,4,5-trimethoxybenzoyl ester analogue of epicatechin-3-gallate. J Med Chem. 2008 Apr 10;51(7):2018-26. doi: 10.1021/jm701346h. Epub 2008 Mar 7. PubMed PMID: 18324763.
AÑO: 2008; IF: 4.898
Autores:
Gonzalez-Muñoz C, Nieto-Cerón S, Cabezas-Herrera J, Hernández-Cascales J. Glucagon increases contractility in ventricle but not in atrium of the rat heart. Eur J Pharmacol. 2008 Jun 10;587(1-3):243-7. doi: 10.1016/j.ejphar.2008.04.001. Epub 2008 Apr 8. PubMed PMID: 18474367.
AÑO: 2008; IF: 2.787
Autores:
Muñoz-Delgado E, Montenegro MF, Morote-García JC, Campoy FJ, Cabezas-Herrera J, Kovacs G, Vidal CJ. The expression of cholinesterases in human renal tumours varies according to their histological types. Chem Biol Interact. 2008 Sep 25;175(1-3):340-2. doi: 10.1016/j.cbi.2008.04.003. Epub 2008 Apr 12. PubMed PMID: 18482720.
AÑO: 2008; IF: 3.077
Navarro-Perán E, Cabezas-Herrera J, Sánchez-Del-Campo L, García-Cánovas F, Rodríguez-López JN. The anti-inflammatory and anti-cancer properties of epigallocatechin-3-gallate are mediated by folate cycle disruption, adenosine release and NF-kappaB suppression. Inflamm Res. 2008 Oct;57(10):472-8. doi: 10.1007/s00011-008-8013-x. PubMed PMID: 18830563.
AÑO: 2008; IF: 1.457
Autores:

Instituto de Investigación Sanitaria Acreditado

ISCII

Fondo Social Europeo "El FSE Invierte en tu futuro"

Fondo Social Europeo

Sello de Calidad Europeo "HR Excellence in Research"

HRS4R